Visionable Appoints First CCO Following Rapid Growth in 2020

VisionableBritish health technology company Visionable has announced the appointment of David Walker to the newly created position of Chief Commercial Officer (CCO), effective immediately. Visionable redesigns healthcare through a digital collaboration platform which enables clinicians to deliver better patient outcomes.

The expansion of the business’ Executive Leadership team follows Visionable’s rapid growth in 2020, which saw £17 million of investment that the company raised in Series A and Series A1 funding rounds.

Visionable has appointed Walker to capitalise on its existing success. The company’s first CCO, Walker will be responsible for developing and creating new partnerships with international organisations to expand Visionable's presence in thriving markets. He will also be identifying new markets where the company’s technology can make huge differences to current practices and efficiencies, also overseeing the expansion of the team as Visionable grows.

Walker has leadership experience in a range of industries, having held senior commercial roles at Sky Television, Dyson, fintech Neyber, and most recently as CCO of AI based technology company Winnow. His experience in creating compelling propositions from innovative products places him in a unique position to understand and deliver on Visionable's current offering and messaging.

Commenting on his new appointment, David Walker said, "I was drawn to Visionable because of the company’s clear dedication to its mission to make healthcare more equitable and accessible for all and its proposition that is changing healthcare as we know it: creating advanced, efficient systems that deliver better outcomes for both patients and professionals."

"Visionable is at an exciting phase of its development, experiencing exceptional demand, poised to scale up and with patented and unique technology to support its vision. I'm delighted to join the Visionable team and be involved in this next stage of the company's growth."

CEO and co-founder of Visionable, Alan Lowe, said, "David has proved his ability, throughout a stellar career, to boost a company’s market share by selling value rather than price, a principle that is intrinsic to Visionable. I’m delighted to welcome David as CCO to our expanding executive team and look forward to working closely with him as we forge partnerships and enter new markets to improve equity in healthcare and deliver better patient outcomes."

About Visionable

Visionable is a healthcare technology company, established in 2015, that provides a digital collaboration platform for clinicians to deliver better patient care. Designed by founders who have worked within the NHS and who continue to partner closely with NHS clinicians, the platform has been created to develop fit-for-purpose digital care pathways and virtual care consultations. Used by NHS hospitals and Trusts, Visionable has delivered and improved patient flow, facilitated quicker decision making and improved patient experience across multiple care settings and specialities such as stroke. This extends to patient consultations, remote diagnostics, telehealth solutions, multidisciplinary teams, virtual visits, and critical patient services.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...